Posted in | News

Goodrich to Supply Various Parts for US Air Forces Joint Surveillance Target Attack Radar System

Goodrich Corporation will be supplying various products and services including thrust reversers, inlets and engine and pylon installation systems and equipment in support of the U.S. Air Force's Joint Surveillance Target Attack Radar System (JSTARS) aircraft fleet re-engining program as announced today by the U.S. Air Force and Northrop Grumman.

According to Curtis Reusser, President of Goodrich's Aerostructures division, "This contract is the long expected fulfillment of the modernization of the JSTARS fleet, increasing the aircraft's performance and efficiency and extending its life. We expect that this modernization will lead the way to re-engining other Boeing 707 military assets including the U.S. Air Force's AWACs."

The re-engining program is designed to improve the fuel efficiency, extend the range and reduce the noise and exhaust emissions of the fleet of 19 U.S. Air Force JSTARS aircraft.

In 2002 Goodrich was selected by Northrop Grumman after a best value competition was conducted under direction of the U.S. Air Force. Northrop had selected Pratt & Whitney JT8D-219 engines equipped with Goodrich's nacelle system components to modernize its JSTARS aircraft fleet.

JSTARS is a long-range, air-to-ground surveillance system that locates, classifies and tracks ground targets in all weather conditions. JSTARS consists of an airborne platform with a multi-role radar system and mobile ground station modules. The airborne platform is a modified Boeing 707 aircraft designated as the E-8C.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.